Literature DB >> 7508724

Neonatal disease induced by SIV infection of the rhesus monkey (Macaca mulatta).

R P Bohm1, L N Martin, B Davison-Fairburn, G B Baskin, M Murphey-Corb.   

Abstract

Seven 72-hr-old Indian origin rhesus monkeys (Macaca mulatta) were inoculated with 10 animal ID50 of SIV/DeltaB670. Nine age-matched animals were used as uninoculated controls. All seven inoculated animals became infected as verified by viral isolation and SIV p26 antigenemia. Five of seven infected animals died within a mean of 31 days (range, 26-41 days), with high levels of antigenemia beginning 1-2 weeks postinoculation (PI) that persisted until death. Absolute lymphocyte numbers were within normal limits in all animals in both groups throughout the study. Inoculated animals that died within a mean of 31 days (short-term survivors) had significantly lower numbers of CD4+CD29+ (helper/inducer) lymphocytes than did long-term surviving inoculated animals through 3 weeks PI. Numbers of CD4+ lymphocytes were no different when controls were compared to all inoculated animals through 4-5 weeks PI. The two inoculated animals surviving 216 and 423 days PI (long-term survivors) did demonstrate declining CD4+ cells, but only late in disease. CD8+ lymphocytes were significantly lower in short-term survivors when compared to long-term survivors through 5 weeks PI. Antibody production against SIV viral proteins was detected only in the long-term survivors and was similar to results from past studies in juveniles. Clinical signs in the inoculated group were consistent with those seen in past studies on older animals. Persistent bacterial infections, primarily of the GI and respiratory tracts, were seen in the infected group. Aside from the lack of some opportunistic infections such as cytomegalovirus (CMV) and Pneumocystis carinii, necropsy findings were not different when compared to past studies on juvenile animals.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7508724     DOI: 10.1089/aid.1993.9.1131

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  10 in total

1.  Shortening of the symptom-free period in rhesus macaques is associated with decreasing nonsynonymous variation in the env variable regions of simian immunodeficiency virus SIVsm during passage.

Authors:  P J Valli; V V Lukashov; J L Heeney; J Goudsmit
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

2.  Structured-tree topology and adaptive evolution of the simian immunodeficiency virus SIVsm envelope during serial passage in rhesus macaques according to likelihood mapping and quartet puzzling.

Authors:  P J Valli; J Goudsmit
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Identification of enteropathogenic Escherichia coli in simian immunodeficiency virus-infected infant and adult rhesus macaques.

Authors:  K G Mansfield; K C Lin; J Newman; D Schauer; J MacKey; A A Lackner; A Carville
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

4.  Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses.

Authors:  Kristina Abel; Bapi Pahar; Koen K A Van Rompay; Linda Fritts; Clarissa Sin; Kimberli Schmidt; Roxana Colón; Mike McChesney; Marta L Marthas
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes.

Authors:  Ashley N Nelson; Ria Goswami; Maria Dennis; Joshua Tu; Riley J Mangan; Pooja T Saha; Derek W Cain; Alan D Curtis; Xiaoying Shen; George M Shaw; Katharine Bar; Michael Hudgens; Justin Pollara; Kristina De Paris; Koen K A Van Rompay; Sallie R Permar
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

Review 6.  The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies.

Authors:  Kristina Abel
Journal:  Curr HIV Res       Date:  2009-01       Impact factor: 1.581

7.  Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS.

Authors:  K K Van Rompay; M G Otsyula; M L Marthas; C J Miller; M B McChesney; N C Pedersen
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

8.  Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques.

Authors:  M L Marthas; K K van Rompay; M Otsyula; C J Miller; D R Canfield; N C Pedersen; M B McChesney
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Induction of simian AIDS in infant rhesus macaques infected with CCR5- or CXCR4-utilizing simian-human immunodeficiency viruses is associated with distinct lesions of the thymus.

Authors:  R A Reyes; Don R Canfield; Ursula Esser; Lourdes A Adamson; Charles R Brown; Cecilia Cheng-Mayer; Murray B Gardner; Janet M Harouse; Paul A Luciw
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Protective role of the virus-specific immune response for development of severe neurologic signs in simian immunodeficiency virus-infected macaques.

Authors:  S Sopper; U Sauer; S Hemm; M Demuth; J Müller; C Stahl-Hennig; G Hunsmann; V ter Meulen; R Dörries
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.